Skip to main content
. 2018 Mar 10;12(3):168–173. doi: 10.1016/j.optom.2018.01.002

Table 2 Comparison of.

characteristics of thalassemic patients based on the type of chelator they received1

Duration of blood transfusion (Year) Serum ferritin level (mg/L) Chelator dosage (mg/kg/day)
Desferal Group 22.4 ± 4.14 (14-29) 2575 ± 1678(400-7000) 36.82 ± 9.56 (16-65)
Osveral Group 18.53 ± 3.86 (10-28) 1951 ± 1336 (575-7000) 24.13 ± 5.59 (8-35)
P-Value 0.000 0.11 0.000
1

Independent sample T Test used for analysis